Medical Journals

Identification of Functional Domains in Sarcoglycans Essential for Their Interaction and Plasma Membrane Targeting.

Authors:
  • Chen Jiwei
  • Shi Weixing
  • Zhang Yuguang
  • Sokol Randi
  • Cai Hong
  • Lun Mingyue
  • Moore Brian F
  • Farber Matthew J
  • Stepanchick Joel S
  • Bönnemann Carsten G
  • Chan Yiu-mo Michael

From: Sigfried and Janet Weis Center for Research, M.C. 26-11, the Geisinger Clinic, 100 North Academy Avenue, Danville, PA 17822, USA.

Experimental cell research

  • Publish Date: May 2006
  • ISSN: 0014-4827
  • Volume: 312
  • Issue: 9
  • Pages: 1610-25
  • Medium: Print
  • Language: English
  • Citation (JAMA): Chen Jiwei, Shi Weixing, Zhang Yuguang, et al. Identification of Functional Domains in Sarcoglycans Essential for Their Interaction and Plasma Membrane Targeting.. Exp. Cell Res. May 2006;312:1610-25

Abstract

Mutations in sarcoglycans have been reported to cause autosomal-recessive limb-girdle muscular dystrophies. In skeletal and cardiac muscle, sarcoglycans are assembled into a complex on the sarcolemma from four subunits (alpha, beta, gamma, delta). In this report, we present a detailed structural analysis of sarcoglycans using deletion study, limited proteolysis and co-immunoprecipitation. Our results indicate that the extracellular regions of sarcoglycans consist of distinctive functional domains connected by proteinase K-sensitive sites. The N-terminal half domains are required for sarcoglycan interaction. The C-terminal half domains of beta-, gamma- and delta-sarcoglycan consist of a cysteine-rich motif and a previously unrecognized conserved sequence, both of which are essential for plasma membrane localization. Using a heterologous expression system, we demonstrate that missense sarcoglycan mutations affect sarcoglycan complex assembly and/or localization to the cell surface. Our data suggest that the formation of a stable complex is necessary but not sufficient for plasma membrane targeting. Finally, we provide evidence that the beta/delta-sarcoglycan core can associate with the C-terminus of dystrophin. Our results therefore generate important information on the structure of the sarcoglycan complex and the molecular mechanisms underlying the effects of various sarcoglycan mutations in muscular dystrophies.

Mesh Headings (Keywords): Amino Acid Sequence, Animals, Binding Sites, COS Cells, Cell Membrane, Cercopithecus aethiops, Cysteine, Dystrophin, Glycosylation, Immunoprecipitation, Mice, Models, Molecular, Molecular Sequence Data, Mutation, Protein Binding, Protein Subunits, Protein Transport, Rats, Sarcoglycans, Sequence Homology, Amino Acid, Transfection


Check for Full Text / PubMed Unique Identifier (PMID): 16524571


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.